Borosil Scientific Ltd (BOROSCI) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Borosil Scientific Ltd on NSE and BSE, with an AI summary of each filing.
Investor Presentation for the quarter & half year ended September 30, 2026
Investor Presentation · 31 Oct 2026, 7:18 pm
Borosil Scientific Reports Strong Q2FY27 Growth and Strategic Expansions Borosil Scientific delivered Q2FY27 consolidated net sales of ₹115.0 Cr, up 7.5% YoY, with EBITDA rising 29.4% YoY to ₹11.0 Cr and PAT surging 86.3% YoY to ₹5.3 Cr. H1FY27 net sales rose 9.3% YoY to ₹221.7 Cr, while PAT stood at ₹9.7 Cr. The company is investing ₹60 Cr to expand glassware capacity from 15 lakh to 108 lakh units annually by Mar'27 and ₹70 Cr in backward integration for a borosilicate glass tubing furnace by Mar'28, targeting a 12-14% medium-term revenue CAGR.
Borosil Scientific Limited has informed the Exchange about Capacity addition - Setting up of tubing furnace
Outcome · 28 Oct 2026, 11:43 pm
Borosil Scientific Limited has submitted to the Exchange, the financial results for the quarter and half year ended September 30, 2026.
Outcome · 28 Oct 2026, 11:41 pm
Borosil Scientific Limited has informed the Exchange regarding Outcome of Board Meeting held on October 28, 2026.
Outcome · 28 Oct 2026, 11:34 pm
Outcome of the Board Meeting
Financial Result · 28 Oct 2026, 11:29 pm
Intimation under Regulation 30 of the SEBI Listing Regulations
Others (Uncategorized) · 28 Oct 2026, 11:20 pm
Borosil Scientific Reports Q2 FY27 Results and Approves Rs. 70 Crore Backward Integration Capex Borosil Scientific approved setting up a Borosilicate 3.3 glass tubing furnace at Bharuch with 20 MT/day capacity, investing up to Rs. 70 crore via internal accruals/debt to enable backward integration by 31st Mar'28. For Q2 ended 30th Sep'26, consolidated revenue grew 7.5% YoY to Rs. 114.96 crore. Net profit rose 86.4% YoY to Rs. 5.31 crore. In H1 ended 30th Sep'26, consolidated revenue reached Rs. 221.72 crore with PAT turning around to Rs. 9.68 crore from a loss of Rs. 1.27 crore YoY.
Outcome of the Board Meeting Held on October 28, 2026
Outcome · 28 Oct 2026, 11:15 pm
Borosil Scientific Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 11,496 (+7.5% YoY | +7.7% QoQ) ■ EBITDA: 1,070 (+33.4% YoY | +26.6% QoQ) ■ EBITDA Margin (%): 9.3 (+180 bps YoY | +139 bps QoQ) ■ PAT: 531 (+83.7% YoY | +21.5% QoQ) ■ EPS (INR): 0.60 (+87.5% YoY | +22.4% QoQ) Borosil Scientific Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance Scientific - Laboratory Glass & equipment and Process System ■ Revenue: 7,905 (+8.3% YoY | +15.6% QoQ) ■ EBIT: 1,327 (+2.0% YoY | +36.7% QoQ) ■ EBIT Margin (%): 16.8 (-103 bps YoY | +259 bps QoQ) Primary Pharma Packaging ■ Revenue: 2,096 (+21.4% YoY | -9.2% QoQ) ■ EBIT: -260 (+49.3% YoY | -384.0% QoQ) ■ EBIT Margin (%): -12.4 (+1731 bps YoY | -1010 bps QoQ) Consumer Glassware ■ Revenue: 1,496 (-10.2% YoY | -2.2% QoQ) ■ EBIT: 78.5 (-25.7% YoY | -2.3% QoQ) ■ EBIT Margin (%): 5.2 (-109 bps YoY | -0 bps QoQ)
To consider and approve the unaudited financial results for the period ended September 30, 2026
Intimation · 28 Oct 2026, 5:30 am
BOROSIL SCIENTIFIC LIMITED has informed the Exchange about Board Meeting to be held on 28-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 28 Oct 2026, 5:30 am
Borosil Scientific Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Intimation · 28 Oct 2026, 5:30 am
Borosil Scientific Schedules Board Meeting to Approve Q2 and H1 FY27 Results Borosil Scientific Limited has scheduled a Board of Directors meeting on 28th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th Sep'26. Additionally, the trading window for dealing in the company's equity shares, which has been closed for designated persons and their immediate relatives since 1st Oct'26, will remain closed until 48 hours following the declaration of the financial results.
The Voting Results and Scrutinizer''s Report for the 35th AGM is attached.
Annual General Meeting · 26 Sept 2026, 1:19 am
The Proceedings of the 35th AGM is attached
Annual General Meeting · 25 Sept 2026, 10:56 pm
Cessation of Senior Management Personnel
Change in Management · 24 Sept 2026, 12:29 am
Borosil Scientific Announces Resignation of Senior Management Personnel Kailash Motwani Borosil Scientific Limited announced that Mr. Kailash Motwani, Head - Operations (Pune & Goel Scientific Glass Works Limited, a material subsidiary) and designated Senior Management Personnel, has resigned due to personal reasons. The cessation is effective immediately from 23rd Sep'26.
Outcome of the Board Meeting
Others (Uncategorized) · 22 Sept 2026, 7:03 pm
Borosil Scientific Approves Rs. 60 Crore Glassware Capacity Expansion in Bharuch Borosil Scientific Limited's Board approved a Rs. 60 crore capex plan on 22nd Sep'26 to establish an additional glassware manufacturing facility in Bharuch, Gujarat. Driven by rising demand from Borosil Limited, the expansion will increase annual production capacity from ~15 lakh units (currently at ~87% utilization) to ~108 lakh units. The project will be funded via internal accruals and/or borrowings, with commercial production scheduled by Mar'27. The company will also seek subsidies under the Viksit Gujarat Industrial Policy 2026.
Intimation under Regulation 30 of the SEBI Listing Regulations- Capacity Addition
Others (Uncategorized) · 22 Sept 2026, 6:54 pm
Borosil Scientific Approves Rs. 60 Crore Glassware Capacity Expansion in Gujarat Borosil Scientific's Board approved a Rs. 60 crore capex to establish an additional glassware manufacturing facility in Bharuch, Gujarat, on 22nd Sep'26. The project will expand capacity from ~15 lakh units per annum (currently operating at ~87% utilization) to ~108 lakh units per annum by Mar'27. Funded via internal accruals and/or borrowings, the expansion aims to meet surging sourcing demand from Borosil Limited. The company will also seek eligible subsidy benefits under the Viksit Gujarat Industrial Policy 2026.
Annual Report for FY 2025-26
Others (Uncategorized) · 02 Sept 2026, 4:20 am
Letter Containing Web-Link of the Annual Report for FY 2025-26 to non-email cases
Annual Report · 01 Sept 2026, 10:45 pm
Annual Report for FY 2025-26 including Notice of 35th AGM scheduled to be held on September 25, 2026
Annual General Meeting · 01 Sept 2026, 5:37 pm
35th Annual General Meeting of the Company is scheduled to be held on Friday, September 25, 2026 at 11:00 a.m. through VC/OAVM.
Annual General Meeting · 28 Aug 2026, 4:57 pm
Intimation of allotment of 4,475 equity shares against stock options exercised under the Company''s ESOP Scheme
Others (Uncategorized) · 14 Aug 2026, 1:03 am
Borosil Scientific Allots Equity Shares Under Employee Stock Option Scheme Borosil Scientific allotted 4,475 new equity shares on 13 Aug'26 following the exercise of options under its ESOP scheme. The shares, with a face value of Re. 1/-, were issued at an exercise price of Rs. 141/- each. This allotment increases the company's issued and paid-up share capital to Rs. 8,89,51,525, comprising 8,89,51,525 equity shares. The newly allotted shares will rank pari-passu with existing equity shares. This action results in minor equity dilution.
Investor Presentation on Company''s performance - Q1-FY 2027
Investor Presentation · 05 Aug 2026, 11:45 pm
Borosil Scientific Q1FY27: Strong YoY Growth Across Metrics For Q1FY27, Borosil Scientific reported consolidated net sales of ₹106.8 Cr, up 11.2% YoY. EBITDA grew 50.1% YoY to ₹8.7 Cr, with margins expanding to 8.2% from 6.0%. PAT turned positive at ₹4.4 Cr compared to a loss of ₹4.2 Cr YoY. The Glassware segment was the key driver, with sales growing 19.0% YoY, led by a 31.6% rise in Pharma Packaging. The Scientific segment grew 5.6% YoY. The company targets a medium-term revenue CAGR of 12-14%, driven by exports and new products.
Outcome of Board Meeting
Financial Result · 03 Aug 2026, 11:27 pm
Borosil Scientific Approves Q1FY27 Results and ESOP Modifications Borosil Scientific's board, on 03 Aug '26, approved Q1FY27 results and ESOP scheme changes. Consolidated Profit After Tax for the quarter ended 30 Jun '26 was Rs. 435.51 lakhs, a significant turnaround from a loss of Rs. 420.96 lakhs YoY, but down from Rs. 2,724.59 lakhs QoQ. Consolidated revenue grew 11.2% YoY to Rs. 10,675.23 lakhs. Key ESOP modifications include allowing secondary share acquisition for option exercise and increasing the maximum grant discount from 10% to 20% for the BSL ESOS scheme.
Outcome of the Board Meeting Held on August 03, 2026
Outcome · 03 Aug 2026, 11:19 pm
Borosil Scientific Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs) ■ Revenue: 10,675 (+11.2% YoY | -25.4% QoQ) ■ EBITDA: 846 (+73.5% YoY | -73.7% QoQ) ■ EBITDA Margin (%): 7.9 (+284 bps YoY | -1451 bps QoQ) ■ PAT: 437 (Loss to Profit YoY | -83.9% QoQ) ■ EPS (INR): 0.49 (Loss to Profit YoY | -84.0% QoQ) Borosil Scientific Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs) Segmental Performance Scientific - Laboratory Glass & equipment and Process System ■ Revenue: 6,668 (+5.6% YoY | -39.2% QoQ) ■ EBIT: 936 (+11.5% YoY | -72.5% QoQ) ■ EBIT Margin (%): 14.0 (+74 bps YoY | -1705 bps QoQ) Glassware ■ Revenue: 3,836 (+19.0% YoY | +20.8% QoQ) ■ EBIT: 19.0 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 0.5 (Loss to Profit YoY | Loss to Profit QoQ) Others ■ Revenue: 171 (+175.6% YoY | -5.3% QoQ) ■ EBIT: 43.0 (+79.6% YoY | -11.8% QoQ) ■ EBIT Margin (%): 25.1 (-1343 bps YoY | -183 bps QoQ)
Borosil Scientific Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Intimation · 03 Aug 2026, 5:30 am
Borosil Scientific to Announce Q1FY27 Results on Aug 3, 2026 Borosil Scientific Ltd. has scheduled a Board of Directors meeting for Mon, 03 Aug '26. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the first quarter ending Jun 30, 2026. The trading window for designated persons, which closed on Jul 01, '26, will remain closed until 48 hours after the results are declared.
Change in Senior Managerial Personnel of the Company
Change in Management · 15 Jul 2026, 3:51 am
Borosil Scientific Announces Senior Management Restructuring Borosil Scientific announced that Mr. Sharad Tiwari, Head - Sales (Domestic & International) for Pharmaceutical Primary Packaging, has ceased to be a Senior Managerial Personnel effective 14th Jul'26. The change is due to a revision in the company's internal reporting structure. Mr. Tiwari will continue to be associated with the company in a different capacity. This disclosure was made under Regulation 30 of SEBI Listing Regulations.